Simpler HIV treatment tested specifically for trans women
Disease control
Recruiting now
This study is testing whether a simpler, two-drug HIV treatment works well for transgender women who already have their virus under control with standard three-drug therapy. Researchers will switch 50 participants to the two-drug combination and follow them for 48 weeks to see if…
Phase: PHASE4 • Sponsor: UBATEC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC